Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model-Reference-Cited by-同舟云学术

Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model

Published:2017-10-18 Issue:10 Volume:12 Page:e0185099
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Razazan Atefeh,Behravan Javad,Arab Atefeh,Barati Nastaran,Arabi Leila,Gholizadeh Zahra,Hatamipour Mahdi,Reza Nikpoor Amin,Momtazi-Borojeni Amir Abbas,Mosaffa Fatemeh,Ghahremani Mohamad Hosein,Jaafari Mahmoud Reza

Funder

School of Advanced Technologies in Medicine, Tehran University of Medical Sciences

Biotechnology Research Center Research Center, Mashhad University of Medical Sciences

Nanotechnology Research Center, Mashhad University of Medical Sciences

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference68 articles.

1. Biology of HER2 and its importance in breast cancer;Y Yarden;Oncology,2001

2. The HER2 receptor in breast cancer: pathophysiology, clinical use, and new advances in therapy;Z Mitri;Chemotherapy research and practice,2012

3. Cancer immunotherapy: moving beyond current vaccines;SA Rosenberg;Nature medicine,2004

4. Cancer vaccines and immunotherapy;S Dermime;British medical bulletin,2002

5. Vaccines for tumour prevention;P-L Lollini;Nature Reviews Cancer,2006

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Canine Mammary Tumors: Classification, Biomarkers, Traditional and Personalized Therapies;International Journal of Molecular Sciences;2024-03-01

2. Rapid liposomal formulation for nucleolin targeting to rhabdomyosarcoma cells;European Journal of Pharmaceutics and Biopharmaceutics;2024-01

3. Advances in Polymeric Micelles: Responsive and Targeting Approaches for Cancer Immunotherapy in the Tumor Microenvironment;Pharmaceutics;2023-11-13

4. Improving the efficacy of peptide vaccines in cancer immunotherapy;International Immunopharmacology;2023-10

5. Introduction of a new recombinant vaccine based on GRP78 for breast cancer immunotherapy and evaluation in a mouse model;BioImpacts;2023-09-18